Nephrology Perspective and Journal Articles

• Wisdom From a Scottish GP: The Lost Art of Convalescence   The final Medicine and the Machine podcast guest, physician and author Gavin Francis, shares his approach to keeping his occupation rewarding and satisfying.
  Medscape, November 28, 2023
• Air Filtration Best Intervention Against Respiratory Viruses?   Even mask "supporters" don't like having to wear them, so perhaps we can find a better way to protect us from respiratory viruses.
  Medscape, November 27, 2023
• Diabetes and Metabolism Updates From ASN 2023   Highlights in diabetes and metabolism from ASN 2023 include the AYAME trial, examining bardoxolone methyl in diabetic kidney disease, as well as a novel aldosterone synthase inhibitor and zibotentan.
  Medscape, November 27, 2023
• Glomerular Disease Updates From ASN 2023   Updates on glomerular diseases from ASN 2023 include data from the NeflgArd trial examining Nefecon for immunoglobulin A nephropathy and the benefits of sparsentan as reported by two trials.
  Medscape, November 22, 2023
• Leveraging the Million Veteran Program Infrastructure and Data for a Rapid Research Response to COVID-19 The Million Veteran Program was launched to better understand how genes, lifestyle, military experience, and environmental exposures interact to influence health and illness in veterans.
  Federal Practitioner, November 22, 2023
• VA Research and COVID-19 The impressive collection of articles in this special issue provides a snapshot of the large-scale, all-hands approach the VHA adopted during the COVID-19 public health crisis.
  Federal Practitioner, November 22, 2023
• 20 Best Holiday Gift Ideas for RNs and NPs From pampering their hard-working hands and feet to personalizing their work essentials, find the perfect present for your favorite nurse.
  Medscape Features Slideshows, November 22, 2023
• S2 Episode 6: Rare Disease: Is It Membranous Nephropathy?   Join experts Drs Matthew Sparks and Laurence Beck as they discuss the diagnosis and management of membranous nephropathy, a rare kidney disease.
  Medscape, November 21, 2023
• A Better Way to Control Blood Pressure Follow the example of a primary care practice in Ohio that has successfully achieved > 90% blood pressure control in its patients with hypertension.
  Medscape Internal Medicine, November 17, 2023
• Treatment of Favorable-Risk Advanced Renal Cell Carcinoma   Experts discuss strategies for treating patients with favorable-risk advanced renal cell carcinoma in light of IMDC guidelines and recent prospective studies.
  Medscape, November 16, 2023
• IKCS 2023: New Advances in Metastatic Kidney Cancer   Dr Katy Beckermann highlights a new tyrosine kinase inhibitor and the unique collaborative discussions shaping the future of kidney cancer care, as reported at IKCS 2023.
  Medscape, November 15, 2023
• AHA 2023 ARTESIA Doesn't Answer a Common Question in Cardiology The trial on apixaban vs aspirin in subclinical atrial fibrillation did not provide an easy answer on whether to anticoagulate patients with these common arrhythmias, writes John Mandrola, MD.
  theheart.org on Medscape, November 15, 2023
• Infographic: Careers That Tempt Doctors to Leave Medicine Physicians who are thinking about leaving the practice of medicine reveal which nonclinical career options most interest them.
  Medscape, November 15, 2023
• Treating Sarcopenia Requires a Muscular Approach Decreased muscle mass is a key harbinger of adverse health outcomes. Here, experts share their advice for combating it.
  Medscape Gastroenterology, November 14, 2023
• Renal Cell Carcinoma Highlights From ESMO 2023   Dr Brian Rini reviews key studies on renal cell carcinoma from ESMO 2023, including several LITESPARK trials examining belzutifan, and the RENOTORCH trial from China looking at a IO/TKI combination.
  Medscape, November 14, 2023
• The Future of Medicine Is RNA   Short interfering RNA drugs could be the next big game changers in pharmacotherapeutics.
  Medscape, November 13, 2023
• Is It Time for Cardiologists to Treat Obesity?   Cardiologists Michelle O'Donoghue and Nicholas Marston discuss the "game changer" trial at AHA showing that GLP-1 agonist semaglutide reduced CV events in patients with ASCVD and overweight/obesity.
  theheart.org on Medscape, November 13, 2023
• Artificial Womb Brings Tough Choices, But Who Tests It?   The artificial womb that is being developed could potentially save very premature infants, but testing it raises many issues.
  Medscape Business of Medicine, November 13, 2023
• AHA 2023 Positive Results From SELECT Begins a New Era in Cardiology The GLP-1 agonist lowered cardiovascular events in overweight patients with CVD. While questions remain on how it works, this cardiologist sees this as a call to change societal norms around obesity.
  theheart.org on Medscape, November 12, 2023
• AI Is Here. Is Your Practice Ready?   In this live panel, Dr Eric Topol, Dr Arjun Manrai, and Dr Ted A. James give their perspectives on AI's capabilities in diagnosis, treatment, precision medicine, and more.
  Medscape, November 10, 2023